Kohei Miyazono Selected Research

Kohei Miyazono Research Topics

Disease

98	Neoplasms (Cancer) 03/2022 - 01/2002
14	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2004
14	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2005
12	Carcinogenesis 01/2022 - 02/2003
11	Carcinoma (Carcinomatosis) 01/2019 - 12/2004
8	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 02/2004
8	Fibrosis (Cirrhosis) 08/2018 - 02/2007
6	Glioma (Gliomas) 01/2022 - 11/2009
5	Inflammation (Inflammations) 01/2021 - 07/2007
5	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2021 - 12/2008
5	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 02/2003
5	Stomach Neoplasms (Stomach Cancer) 03/2014 - 02/2003
4	Adenocarcinoma of Lung 07/2018 - 04/2009
4	Prostatic Neoplasms (Prostate Cancer) 02/2016 - 12/2004
4	Adenocarcinoma 01/2011 - 02/2007
4	Pathologic Processes 01/2011 - 10/2008
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2018
3	Kidney Neoplasms (Kidney Cancer) 08/2021 - 01/2018
3	Vascular Diseases (Vascular Disease) 11/2019 - 10/2002
3	Glioblastoma (Glioblastoma Multiforme) 11/2019 - 07/2011
3	Lung Neoplasms (Lung Cancer) 02/2012 - 04/2009
2	Triple Negative Breast Neoplasms 03/2022 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2004
2	Hereditary Hemorrhagic Telangiectasia 11/2013 - 12/2002
2	Peritonitis 05/2008 - 11/2007
2	Bone Resorption 02/2008 - 04/2004
2	Familial Primary Pulmonary Hypertension 12/2004 - 09/2002
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Endometrial Neoplasms (Endometrial Cancer) 07/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Mouth Neoplasms (Oral Cancer) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Pulmonary Arterial Hypertension 11/2019
1	Brain Neoplasms (Brain Tumor) 11/2019

Drug/Important Bio-Agent (IBA)

37	Transforming Growth Factor beta (TGF-beta)IBA 06/2019 - 01/2002
31	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2022 - 03/2003
17	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2022 - 09/2002
15	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2003
9	MicroRNAs (MicroRNA)IBA 09/2015 - 07/2009
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2004
8	CytokinesIBA 01/2021 - 10/2008
7	LigandsIBA 03/2022 - 04/2002
6	Phosphotransferases (Kinase)IBA 01/2018 - 12/2004
6	Messenger RNA (mRNA)IBA 05/2015 - 11/2007
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019 - 02/2003
5	Transcription Factors (Transcription Factor)IBA 01/2018 - 04/2002
5	Transforming Growth Factor-beta Type I ReceptorIBA 12/2008 - 12/2002
4	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2017
4	Activin Receptors (Activin Receptor)IBA 01/2021 - 11/2013
4	Pharmaceutical PreparationsIBA 05/2020 - 04/2010
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2021 - 05/2012
3	Epidermal Growth Factor (EGF)IBA 01/2020 - 06/2003
3	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2016
3	Growth Differentiation Factor 2IBA 01/2017 - 05/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 07/2008
3	Type I Bone Morphogenetic Protein ReceptorsIBA 01/2017 - 12/2004
3	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 06/2011 - 12/2002
3	MicellesIBA 01/2011 - 12/2008
2	Cadherins (E-Cadherin)IBA 01/2022 - 04/2009
2	ChemokinesIBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 02/2003
2	Activins (Activin)IBA 01/2019 - 04/2002
2	Aldehyde DehydrogenaseIBA 01/2018 - 05/2015
2	Therapeutic UsesIBA 01/2017 - 01/2011
2	Peptides (Polypeptides)IBA 02/2016 - 01/2011
2	Biological ProductsIBA 02/2016 - 12/2009
2	Doxycycline (Periostat)FDA LinkGeneric 07/2011 - 12/2004
2	AndrogensIBA 03/2011 - 12/2004
2	Estrogens (Estrogen)FDA Link 03/2011 - 04/2004
2	Lysine (L-Lysine)FDA Link 01/2011 - 12/2008
2	DisulfidesIBA 01/2011 - 04/2010
2	Ethylene Glycol (Monoethylene Glycol)IBA 01/2011 - 12/2008
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2010 - 04/2009
2	Thrombospondin 1IBA 10/2009 - 04/2009
2	Transforming Growth Factor-beta Type II ReceptorIBA 10/2009 - 04/2009
2	Vascular Endothelial Growth Factor CIBA 05/2008 - 11/2007
2	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 10/2007 - 11/2003
2	Bone Morphogenetic Protein 7IBA 12/2004 - 02/2003
2	Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA 12/2004 - 09/2002
1	InterferonsIBA 03/2022
1	Red Fluorescent ProteinIBA 01/2022
1	DNA Methyltransferase 3AIBA 01/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 09/2021
1	EndoglinIBA 08/2021
1	SR 48692IBA 01/2021
1	Cell Surface ReceptorsIBA 01/2021
1	PyrazolesIBA 01/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	NeurotensinIBA 01/2021
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2021
1	pyrazoleIBA 05/2020
1	EphA1 Receptor (Eph Receptor)IBA 11/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2019

Therapy/Procedure

11	Therapeutics 03/2022 - 02/2007
3	Drug Therapy (Chemotherapy) 01/2016 - 11/2009
2	Transplantation 01/2021 - 11/2010